Javier Ena

2.8k total citations
102 papers, 1.7k citations indexed

About

Javier Ena is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Infectious Diseases. According to data from OpenAlex, Javier Ena has authored 102 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Endocrinology, Diabetes and Metabolism, 33 papers in Epidemiology and 26 papers in Infectious Diseases. Recurrent topics in Javier Ena's work include Diabetes Management and Research (19 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (14 papers) and HIV/AIDS drug development and treatment (13 papers). Javier Ena is often cited by papers focused on Diabetes Management and Research (19 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (14 papers) and HIV/AIDS drug development and treatment (13 papers). Javier Ena collaborates with scholars based in Spain, United States and Chile. Javier Ena's co-authors include V. Valls, Concha Amador, Francisco Pasquau, Ricardo Gómez‐Huelgas, Emilia Cercenado, Emilio Bouza, Victoria Ortiz de la Tabla, Francisco J. Arjona, Calvin M. Kunin and Juana Carretero‐Gómez and has published in prestigious journals such as JAMA, Clinical Infectious Diseases and International Journal of Molecular Sciences.

In The Last Decade

Javier Ena

91 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Javier Ena Spain 24 630 610 238 226 187 102 1.7k
Murray A. Abramson United States 17 459 0.7× 384 0.6× 513 2.2× 420 1.9× 295 1.6× 27 1.9k
Muralidharan Jayashree India 25 565 0.9× 623 1.0× 246 1.0× 287 1.3× 48 0.3× 201 2.3k
Vanessa Stevens United States 22 816 1.3× 766 1.3× 53 0.2× 307 1.4× 170 0.9× 90 1.8k
Rafael Herruzo Spain 28 220 0.3× 393 0.6× 142 0.6× 255 1.1× 53 0.3× 95 1.7k
Jung‐Yien Chien Taiwan 24 855 1.4× 1.0k 1.7× 91 0.4× 325 1.4× 81 0.4× 98 2.1k
Kenneth Lichtenstein United States 24 1.7k 2.7× 1.1k 1.8× 146 0.6× 207 0.9× 573 3.1× 39 3.2k
Patrick G. P. Charles Australia 15 930 1.5× 942 1.5× 78 0.3× 125 0.6× 523 2.8× 36 2.0k
Angelo Pan Italy 24 1.1k 1.7× 550 0.9× 42 0.2× 189 0.8× 287 1.5× 69 2.2k
J. Gray United Kingdom 22 323 0.5× 563 0.9× 57 0.2× 248 1.1× 205 1.1× 78 1.7k
Florent Wallet France 32 632 1.0× 1.3k 2.1× 50 0.2× 489 2.2× 241 1.3× 167 3.2k

Countries citing papers authored by Javier Ena

Since Specialization
Citations

This map shows the geographic impact of Javier Ena's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Javier Ena with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Javier Ena more than expected).

Fields of papers citing papers by Javier Ena

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Javier Ena. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Javier Ena. The network helps show where Javier Ena may publish in the future.

Co-authorship network of co-authors of Javier Ena

This figure shows the co-authorship network connecting the top 25 collaborators of Javier Ena. A scholar is included among the top collaborators of Javier Ena based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Javier Ena. Javier Ena is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ena, Javier, et al.. (2025). Effect of inclisiran on lipoprotein(a) values: A meta-analysis. Atherosclerosis. 407. 119822–119822.
2.
Ena, Javier, et al.. (2024). Efficacy and safety of bemiparin as treatment of venous thromboembolic disease in the elderly. Journal of Evaluation in Clinical Practice. 30(6). 1084–1090.
3.
Carretero‐Gómez, Juana, Francisco Javier Carrasco-Sánchez, José María Fernández Rodríguez, et al.. (2023). Efecto de semaglutida sobre los biomarcadores de la enfermedad del hígado graso en pacientes con diabetes y obesidad. Revista Clínica Española. 223(3). 134–143. 1 indexed citations
4.
Ena, Javier. (2023). La importancia educativa de los casos clínicos para un editor de revistas biomédicas. 8(2). 61–62. 1 indexed citations
5.
Arévalo‐Lorido, José Carlos, et al.. (2023). Glycemic control and prescription profiles in internal medicine inpatients: The role of frailty. European Journal of Internal Medicine. 121(4). 103–108. 2 indexed citations
6.
Carretero‐Gómez, Juana, Francisco Javier Carrasco-Sánchez, J.M. Fernández, et al.. (2022). Effect of semaglutide on fatty liver disease biomarkers in patients with diabetes and obesity. Revista Clínica Española (English Edition). 223(3). 134–143. 8 indexed citations
7.
Carretero‐Gómez, Juana, Pablo Pérez‐Martínez, Francisco Javier Carrasco-Sánchez, et al.. (2022). High-Risk Obesity Phenotypes: Target for Multimorbidity Prevention at the ROFEMI Study. Journal of Clinical Medicine. 11(16). 4644–4644. 7 indexed citations
8.
Ena, Javier, et al.. (2022). Therapeutic-dose anticoagulation or thromboprophylaxis with low-molecular-weight heparin for moderate Covid-19: meta-analysis of randomized controlled trials. Clinical and Experimental Medicine. 23(4). 1189–1196. 4 indexed citations
9.
Ena, Javier, et al.. (2021). Evaluation of FilmArray ME panel for the rapid diagnosis of meningitis–encephalitis in emergency departments. Internal and Emergency Medicine. 16(5). 1289–1295. 5 indexed citations
10.
Ena, Javier, et al.. (2021). Use of antihyperglycaemic therapy with cardiovascular benefit in patients with type 2 diabetes who require hospitalisation: A cross-sectional study. Revista Clínica Española (English Edition). 221(9). 517–528. 1 indexed citations
11.
12.
Ena, Javier, A. Zapatero Gaviría, Juana Carretero‐Gómez, et al.. (2017). Derivation and validation model for hospital hypoglycemia. European Journal of Internal Medicine. 47. 43–48. 16 indexed citations
13.
Cuende, José I., Carlos Lahoz, Pedro Armario, et al.. (2014). Novedades cardiovasculares 2013/2014. Revista Clínica Española. 215(1). 33–42.
14.
Ena, Javier, et al.. (2014). Short-course treatment of latent tuberculosis infection in patients with rheumatic conditions proposed for anti-TNF therapy. Clinical Rheumatology. 34(1). 29–34. 5 indexed citations
15.
Ena, Javier, et al.. (2013). Use of pocket pulse oximeters for detecting peripheral arterial disease in patients with diabetes mellitus. Journal of Diabetes Mellitus. 3(2). 79–85. 5 indexed citations
16.
Ena, Javier, et al.. (2011). Accuracy of ankle–brachial index obtained by automated blood pressure measuring devices in patients with diabetes mellitus. Diabetes Research and Clinical Practice. 92(3). 329–336. 11 indexed citations
17.
Palacios, Rosario, Pablo Rivas, Antonio Ocampo, et al.. (2006). Impact of Syphilis Infection on HIV Viral Load and CD4 Cell Counts in HIV-Infected Patients. JAIDS Journal of Acquired Immune Deficiency Syndromes. 44(3). 356–359. 95 indexed citations
18.
Ena, Javier & V. Valls. (2005). Short-Course Therapy with Rifampin plus Isoniazid, Compared with Standard Therapy with Isoniazid, for Latent Tuberculosis Infection: A Meta-analysis. Clinical Infectious Diseases. 40(5). 670–676. 146 indexed citations
19.
20.
Ena, Javier, et al.. (1992). Cross-Sectional Epidemiology of Phlebitis and Catheter-Related Infections. Infection Control and Hospital Epidemiology. 13(1). 15–20. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Murray A. Abramson Breakdown of academic impact, for papers by Muralidharan Jayashree Breakdown of academic impact, for papers by Vanessa Stevens Breakdown of academic impact, for papers by Rafael Herruzo Breakdown of academic impact, for papers by Jung‐Yien Chien Breakdown of academic impact, for papers by Kenneth Lichtenstein Breakdown of academic impact, for papers by Patrick G. P. Charles Breakdown of academic impact, for papers by Angelo Pan Breakdown of academic impact, for papers by J. Gray Breakdown of academic impact, for papers by Florent Wallet
Rankless by CCL
2026